Browsing Tag
broad-spectrum antiviral
1 post
Bioxytran reports successful clinical trial for ProLectin-M, a broad-spectrum antiviral targeting multiple respiratory viruses
Find out how Bioxytran’s completed randomized trial for ProLectin-M could redefine the antiviral market and reshape biotech investor sentiment.